Article info

Original research
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

Authors

  • Odd L Gammelgaard Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Mikkel G Terp Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Christian Renn PharmaCenter Bonn, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany PubMed articlesGoogle scholar articles
  • Aran F Labrijn Genmab BV, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Oliver Hamaker Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Aaraby Y Nielsen Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Henriette Vever Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Soren WK Hansen Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Morten F Gjerstorff Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Oncology, Odense University Hospital, Odense, Denmark PubMed articlesGoogle scholar articles
  • Christa E Müller PharmaCenter Bonn, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany PubMed articlesGoogle scholar articles
  • Paul WHI Parren Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Immunology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Henrik J Ditzel Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, DenmarkDepartment of Oncology, Odense University Hospital, Odense, Denmark PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Henrik J Ditzel; hditzel{at}health.sdu.dk
View Full Text

Citation

Gammelgaard OL, Terp MG, Renn C, et al
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

Publication history

  • Accepted July 28, 2022
  • First published September 12, 2022.
Online issue publication 
September 12, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.